ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

ANMCO statement: semaglutide in the cardio-nephro-metabolic continuum.

Leonardo De Luca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.